Hikma Pharmaceuticals Plc - Company Profile
Powered by 
All the data and insights you need on Hikma Pharmaceuticals Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date Hikma Pharmaceuticals Plc Strategy Report
- Understand Hikma Pharmaceuticals Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Hikma Pharmaceuticals Plc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US11433072B1 | Grant | Oral dosage forms of ibrutinib | A61K31/519; A61K9/0053; A61K9/4858; A61K9/4866 | September 06, 2022 |
| EP3806827A4 | Search Report | EPINEPHRINSPRÜHFORMULIERUNGEN | A61K31/137; A61K47/02; A61K47/10; A61K47/183; A61K47/186; A61K47/20; A61K47/26; A61K9/0019; A61K9/0043; A61K9/006; A61K9/14; A61P37/08 | March 23, 2022 |
| US20220071977A1 | Application | READY-TO-ADMINISTER FENTANYL FORMULATIONS | A61K31/4468; A61K9/0019 | March 10, 2022 |
| US20220023201A1 | Application | PHENYLEPHRINE HYDROCHLORIDE READY-TO-USE SOLUTION | A61J1/06; A61K31/137; A61K47/02; A61K47/10; A61K47/12; A61K47/183; A61K9/0019; A61K9/08; B65B3/003; B65B55/06; B65B7/16 | January 27, 2022 |
| US11213480B1 | Grant | Phenylephrine hydrochloride ready-to-use solution | A61J1/06; A61K31/137; A61K47/02; A61K47/10; A61K47/12; A61K47/183; A61K9/0019; A61K9/08; B65B3/003; B65B55/06; B65B7/16 | January 04, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer